2012 DEC 3 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Investigators discuss new findings in AIDS/HIV Research. According to news reporting from Boston, Massachusetts, by NewsRx journalists, research stated, "Regulatory T cells (Tregs) are potent immune modulators, but their precise role in HIV pathogenesis remains incompletely understood."
The news correspondents obtained a quote from the research from Massachusetts General Hospital, "Most studies to date have focused on frequencies or phenotypes of 'bulk' Treg populations. However, although antigen-specific Tregs have been reported in other diseases, HIV-1 epitope-specific Tregs have not been described to date."
According to the news reporters, the research concluded: "We here report the first identification of functional HIV-1-Gag-specific regulatory T cells using human leukocyte antigen class II tetramer staining in HIV-1-infected individuals."
For more information on this research see: Identification of HIV-1-specific regulatory T-cells using HLA class II tetramers. Aids, 2012;26(16):2112-2115. Aids can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St, Philadelphia, PA 19106-3621, USA. (Lippincott Williams and Wilkins - www.lww.com; Aids - journals.lww.com/aidsonline/pages/default.aspx)
Our news journalists report that additional information may be obtained by contacting M. Angin, Massachusetts General Hospital, Div Infect Dis, Boston, MA 02114, United States (see also AIDS/HIV Research).
Keywords for this news article include: Boston, HIV/AIDS, RNA Viruses, Retroviridae, Massachusetts, United States, HIV Infections, AIDS/HIV Research, Vertebrate Viruses, Primate Lentiviruses, North and Central America, Viral Sexually Transmitted Diseases
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC